bacteri
viral
infect
occur
earli
recurr
life
therebi
impos
substanti
diseas
burden
besid
caus
clinic
symptom
potenti
role
infect
develop
asthma
syndrom
later
life
also
suggest
howev
whether
bacteri
viral
infect
unmask
host
factor
children
risk
asthma
whether
directli
caus
asthma
remain
unclear
viewpoint
could
justifi
ed
underli
mechan
complex
poorli
understood
recent
role
bacteri
microbiom
emphasis
data
still
spars
futur
studi
need
defi
nitiv
conclus
made
review
discuss
present
knowledg
virus
bacteria
infect
colonis
respiratori
tract
mucos
surfac
includ
timepoint
action
host
factor
relat
infect
eff
ect
childhood
asthma
childhood
asthma
could
result
combin
alter
host
suscept
infecti
agent
live
suff
er
prosper
world
bacteria
virus
damag
caus
bacteria
infecti
agentsi
invad
host
tissu
diseasecaus
organismsi
well
accept
bacteria
trigger
variou
diseas
mani
aff
ect
respiratori
tract
prenat
period
earli
childhood
bacteri
infect
aff
ect
intrauterin
lung
develop
import
development
time
window
bacteria
caus
infect
elicit
adapt
immun
respons
also
popul
habitat
bodi
larg
number
outnumb
human
cell
tenfold
besid
metabol
function
microbiomei
collect
genom
microb
live
insid
human
bodyha
major
eff
ect
develop
immun
respons
earli
life
mice
rais
germfre
condit
show
sever
defi
cienci
immun
respons
prone
develop
experiment
asthma
reconstitut
gut
microbiom
germfre
mice
microbiota
mice
rais
specifi
c
pathogenfre
condit
correct
defi
cit
administ
earli
life
role
lung
microbiom
turn
less
well
known
sever
studi
report
specifi
c
colonis
proteobacteria
bronchoalveolar
lavag
sampl
sputum
patient
asthma
whether
type
colonis
preced
onset
asthma
occur
secondari
airway
infl
ammat
remain
elucid
virus
gener
known
caus
diseas
associ
upper
respiratori
tract
infect
urti
lower
respiratori
tract
infect
lrti
numer
studi
link
earli
viral
lrti
develop
childhood
wheez
asthma
natur
associ
howev
complet
clear
virus
might
predispos
onset
wheez
asthma
equal
conceiv
viral
infect
mere
unmask
host
factor
underli
diseas
suscept
altern
notion
might
justifi
ed
virus
might
trigger
wheez
asthma
therebi
aggrav
airway
infl
ammat
role
bacteri
microbiom
shape
immun
respons
viru
infect
current
unknown
review
fi
rst
discuss
controversi
role
virus
develop
childhood
asthma
review
role
bacteri
microbiom
bacteri
infect
final
discuss
potenti
eff
ect
viral
bacteri
infect
treatment
prevent
childhood
asthma
commonli
identifi
ed
virus
caus
respiratori
tract
infect
children
human
rhinovirus
hrv
respiratori
syncyti
viru
rsv
infl
uenza
parainfl
uenza
virus
coronaviru
adenoviru
human
metapneumoviru
bocaviru
hrv
famili
picornavirida
genu
enteroviru
singlestrand
nonenvelop
positivesens
rna
virus
diff
erent
serotyp
serotyp
subdivid
receptor
major
group
small
intercellular
adhes
molecul
minor
group
low
densiti
lipoprotein
receptor
accord
sequenc
variationsi
hrva
hrvb
late
also
potenti
virul
hrvc
hrv
initi
thought
limit
urti
howev
hrv
abl
spread
replic
lower
airway
thu
might
lead
lrti
rsv
famili
paramyxovirida
genu
pneumoviru
singlestrand
envelop
negativesens
rna
viru
review
classifi
ed
two
subtyp
rsva
rsvb
patient
rsv
produc
mild
symptom
urti
infant
rsv
lead
bronchiol
season
birth
import
predictor
sever
diseas
especi
immunocompromis
prematur
infant
use
pcrbase
viral
diagnost
virus
multipl
coexist
viral
strain
detect
biolog
sampl
patient
respiratori
tract
infect
also
asymptomat
individu
sever
hrv
strain
shown
circul
one
infecti
season
hrv
rna
identifi
ed
nasal
mucu
remnant
previou
infect
long
individu
becom
symptomfre
virus
predispos
asthma
abund
epidemiolog
data
report
associ
respiratori
viral
infect
develop
childhood
wheez
asthma
sever
prospect
studi
studi
populationbas
cohort
investig
children
admit
hospit
symptomat
lrti
tabl
sever
studi
undertook
analys
hrv
rsv
longitudin
tucson
children
respiratori
studi
viral
lrti
fi
rst
year
life
independ
determin
wheez
age
year
tabl
risk
decreas
age
year
accompani
reduct
forc
expiratori
volum
increas
respons
salbutamol
impli
last
chang
regul
airway
smooth
muscl
tone
finnish
studi
replic
fi
nding
show
risk
asthma
confer
virusinduc
lrti
might
decreas
time
tabl
anoth
import
populationbas
birthcohort
tennesse
asthma
bronchiol
studi
tab
investig
children
admit
hospit
visit
outpati
emerg
depart
symptom
bronchiol
secondari
viral
lrti
although
risk
asthma
gener
increas
viral
lrti
infanc
risk
also
depend
age
child
peak
viru
season
maximum
risk
infant
age
around
day
furthermor
risk
diff
ere
winter
month
probabl
domin
rsv
infect
nonwint
month
probabl
domin
hrv
infect
tabl
support
fi
nding
studi
extend
popul
tab
cohort
ad
californian
popul
investig
report
childhood
asthma
case
attribut
infant
lrti
rsv
season
rsv
infect
earli
life
might
associ
longterm
eff
ect
lung
function
chang
airway
tone
might
also
relat
allerg
diseas
sigur
cowork
undertook
observ
studi
infant
admit
hospit
sweden
sever
rsvinduc
lrti
report
rsvinduc
lrti
link
atop
sensitis
allerg
diseas
year
age
increas
risk
atop
sensitis
allerg
diseas
persist
age
year
rsvinduc
lrti
infanc
also
associ
allerg
asthma
howev
fi
nding
restrict
individu
sever
diseas
requir
admiss
hospit
review
discuss
potenti
role
rsv
bronchiol
initi
asthma
possibl
causal
role
viral
infect
establish
intervent
trial
attempt
prevent
viral
infect
therebi
prevent
subsequ
wheez
asthma
passiv
immunis
antibodi
rsv
investig
cowork
undertook
prospect
multicentr
match
doubl
cohort
studi
children
born
prematur
show
administr
palivizumaba
humanis
antibodi
rsv
fusion
protein
associ
signifi
cant
decreas
rel
risk
recurr
wheez
diagnos
doctor
year
age
children
without
famili
histori
asthma
atopi
keenli
anticip
result
maki
trial
robust
multicentr
placebocontrol
doubleblind
randomis
clinic
trial
palivizumab
healthi
preterm
babi
show
number
cumul
wheez
day
fi
rst
year
life
signifi
cantli
p
lower
palivizumab
prophylaxi
moreov
signifi
cant
reduct
number
rsv
infect
hospit
admiss
rsv
report
palivizumab
treatment
group
compar
placebo
group
tabl
rather
caus
asthma
viral
lrti
might
mere
unveil
underli
risk
word
infect
might
trigger
symptom
individu
preexist
host
factor
would
becom
symptomat
anyway
host
factor
includ
alter
airway
function
mechan
genet
background
atop
sensitis
impair
mucos
system
immun
respons
environment
exposur
might
addit
aff
ect
probabl
patient
asthma
exacerb
viral
infect
wheez
symptom
expiratori
fl
ow
limit
function
airway
calibr
airway
mechan
result
fl
utter
airway
wall
whistl
sound
oedema
bronchospasm
chang
airway
mechan
due
lrtiinduc
infl
ammat
narrow
airway
result
wheez
especi
infant
decreas
airway
function
bronchial
hyperrespons
present
acut
wheez
might
also
preced
onset
develop
earli
time
window
might
advers
aff
ect
anatomi
wall
mechan
airway
might
unmask
infect
respiratori
virus
lead
fi
rst
manifest
wheez
promin
host
factor
genet
background
child
directli
aff
ect
lung
growth
develop
induc
chang
immun
respons
histor
linkag
studi
analys
posit
clone
candid
gene
studi
identifi
ed
mani
genet
variant
associ
asthma
sinc
highthroughput
techniqu
becom
less
expens
genomewid
associ
studi
gwass
asthma
report
august
fi
rst
gwa
asthma
describ
locu
chromosom
replic
mani
popul
greatest
eff
ect
childhoodonset
asthma
notabl
smit
cowork
associ
analysi
children
epidemiolog
studi
genet
environ
asthma
egea
show
neither
eff
ect
risk
allel
earli
lrti
asthma
independ
odd
ratio
or
earlyonset
asthma
earli
lrti
higher
carrier
risk
allel
noncarri
p
interact
fi
nding
suggest
earli
rti
uncov
carrier
risk
enhanc
detriment
viral
eff
ect
cowork
confi
rmed
notion
investig
children
childhood
origin
asthma
coast
studi
replic
fi
nding
individu
copenhagen
studi
asthma
childhood
copsac
highrisk
cohort
investig
show
variant
increas
risk
asthma
hrvinduc
lrti
modifi
ed
risk
cohort
or
asthma
homozyg
risk
allel
carrier
coast
studi
copsac
children
least
one
hrvinduc
lrti
compar
copsac
previou
hrvlrti
p
interact
vs
copsac
thomsen
cowork
retrospect
analysi
data
larg
danish
twin
registri
use
advanc
genet
varianc
compon
model
direct
causat
model
show
rsv
infect
indic
genet
predisposit
asthma
seem
caus
asthma
tabl
anoth
import
host
factor
atop
sensitis
atopi
allerg
diseas
independ
associ
subsequ
asthma
associ
earli
persist
sensitis
asthma
last
earli
childhood
adulthood
sensitis
inhal
allergen
childhood
associ
decreas
lung
growth
independ
risk
factor
asthma
later
life
studi
two
australian
birth
cohort
populationbas
rain
studi
highrisk
childhood
asthma
studi
ca
investig
potenti
role
atop
sensitis
complex
interplay
viral
infect
rain
studi
sensitis
age
year
associ
increas
risk
current
asthma
risk
higher
studi
particip
lrti
fi
rst
year
life
ca
kusel
cowork
report
risk
current
asthma
year
diagnos
doctor
persist
wheez
start
age
year
persist
age
year
increas
hrvinduc
lrti
compar
outcom
without
exposur
wherea
rsvinduc
lrti
risk
increas
wheez
tabl
increas
risk
howev
restrict
children
sensitis
age
year
result
followup
age
year
show
similar
trend
children
virusinduc
particularli
febril
lrti
increas
risk
asthma
wheez
pronounc
children
sensitis
age
year
tabl
coast
studi
tabl
risk
wheez
age
year
year
increas
either
hrvinduc
rsvinduc
lrti
fi
rst
year
life
earli
sensitis
predispos
factor
time
cours
event
preced
develop
wheez
hansel
cowork
review
role
mucos
immun
respons
microorgan
develop
asthma
thu
focu
aspect
impair
immun
respons
viral
infect
predispos
asthma
infanc
immun
system
includ
innat
adapt
immun
respons
immatur
compar
immun
attain
adult
evid
suggest
infant
develop
atopi
asthma
particularli
delay
matur
immun
respons
might
predispos
develop
viral
lrti
result
asthma
infanc
dendrit
cell
less
capabl
present
antigen
compar
later
childhood
cell
part
adapt
defenc
allianc
less
abl
produc
cytokin
form
memori
cell
birth
instead
might
even
undergo
apoptosi
upon
antigen
contact
moreov
adapt
immun
respons
neonat
show
inher
thelper
cell
type
bia
matur
thelper
cell
type
respons
lag
bia
pronounc
individu
atop
predisposit
result
less
order
respons
decreas
concentr
contact
pathogen
combin
ineffi
caciou
immun
respons
toward
viral
pathogen
delay
develop
focus
eff
ectiv
respons
relat
increas
number
rti
earli
life
possibl
increas
viral
spread
lower
airway
airway
epithelium
regard
fi
rst
line
defenc
respiratori
virus
role
complex
play
central
part
mucos
immun
although
virus
shown
disrupt
integr
respiratori
mucosa
disrupt
also
compon
asthmat
phenotyp
epitheli
integr
children
asthma
relat
genet
risk
confer
polymorph
gene
encod
serin
proteinas
inhibitor
known
involv
retent
epitheli
barrier
function
robust
consist
fi
nding
confer
preexist
risk
lrti
wheez
relat
environment
tobacco
smoke
et
exposur
either
prenat
postnat
et
shown
aff
ect
earli
lung
function
disrupt
growth
develop
lung
import
time
window
rapid
growth
moreov
link
earli
et
exposur
virusinduc
lrti
later
wheez
asthma
shown
associ
could
attribut
eff
ect
et
matur
innat
immun
respons
could
account
increas
suscept
infect
infant
expos
et
studi
mice
show
et
alter
antivir
immun
respons
therebi
mitig
viral
infect
genet
background
child
might
furthermor
modifi
associ
advers
environment
exposur
premorbid
risk
asthma
smit
cowork
analysi
children
egea
studi
et
exposur
enhanc
eff
ect
earli
viral
lrti
risk
allel
carrier
result
children
histori
et
exposur
specifi
c
genet
background
could
especi
suscept
viral
infect
addit
et
exposur
outdoor
air
pollut
could
play
import
part
trigger
asthma
exacerb
also
induc
alter
airway
function
mechan
immun
respons
lead
asthma
studi
investig
densiti
car
traffi
c
particular
truck
traffi
c
road
close
proxim
child
resid
identifi
ed
exposur
could
direct
eff
ect
lung
growth
might
also
lead
chang
immun
function
exposur
air
pollut
directli
associ
increas
risk
respiratori
infect
infanc
anoth
import
environment
exposur
relat
matern
infant
nutrit
malnutrit
might
directli
aff
ect
respiratori
system
aff
ect
growth
develop
children
mother
expos
dutch
famin
earli
midgest
shown
risk
obstruct
airway
diseas
suggest
direct
nutrit
eff
ect
lung
develop
postnat
airway
mechan
matern
dietari
vitamin
vitamin
e
concentr
pregnanc
invers
relat
wheez
children
wherea
vitamin
e
shown
interfer
airway
develop
via
epigenet
chang
low
serum
vitamin
concentr
relat
respiratori
infect
infant
although
exact
role
vitamin
context
immun
modul
yet
clear
could
import
regul
innat
adapt
immun
respons
human
bodi
harbour
ten
trillion
bacteria
far
number
human
cell
individu
great
variat
bacteri
speci
diff
erent
bodi
site
mucos
surfac
interindividu
divers
much
greater
variat
composit
microbiota
individu
time
gut
microbiom
mainli
studi
mice
human
human
microbiom
project
extens
characteris
faecal
sampl
healthi
individu
unfortun
airway
microbiom
includ
groundbreak
project
therefor
characteris
airway
sampl
healthi
popul
scarc
unlik
gastrointestin
tract
faecal
sampl
easili
obtain
access
airway
particularli
children
restrict
feasibl
studi
technic
issu
compar
microbiom
analys
upper
lower
respiratori
tract
potenti
contamin
bronchoscop
sampl
resolv
nevertheless
conclus
made
children
adult
asthma
seem
primarili
colonis
gammaproteobacteriai
haemophilu
infl
uenza
moraxella
catarrhali
streptococcu
pneumonia
howev
individu
asthma
whether
pattern
colonis
occur
secondari
airway
epithelium
damag
impair
barrier
function
infl
ammatori
chang
airway
primari
caus
diseas
remain
elucid
one
birth
cohort
studi
suggest
colonis
hypopharynx
h
infl
uenza
catarrhali
pneumonia
earli
life
preced
onset
asthma
notabl
risk
associ
colonis
month
age
independ
colonis
later
timepoint
suggest
potenti
window
opportun
diseas
develop
howev
fi
nding
children
mother
asthma
generalis
result
limit
moreov
investig
use
convent
cultur
method
studi
use
dnabas
techniqu
need
might
identifi
increas
varieti
microbiota
furthermor
whether
fi
nding
truli
refl
ect
colonis
lower
airway
mucosa
remain
unclear
studi
use
either
bronchoalveolar
lavag
sampl
sputum
sampl
sampl
hypopharynx
although
bacteria
might
colonis
mucos
surfac
upper
respiratori
tract
fl
uid
review
sputum
lower
airway
true
colonis
mucos
surfac
lower
respiratori
tract
remain
matter
debat
role
abund
gut
microbiom
respiratori
diseas
furthermor
await
elucid
experiment
studi
reconstitut
normal
faecal
microbiom
earli
life
gnotobiot
mice
abolish
risk
asthma
associ
germfre
upbring
whether
gutlung
axi
equal
import
human
particularli
prone
develop
asthma
indirectli
investig
studi
microbiom
gut
infant
could
aff
ect
mode
birth
deliveri
children
born
caesarean
section
colonis
diff
erent
children
vagin
deliv
vagin
fl
ora
could
aff
ect
gut
colonis
infant
aff
ect
infant
risk
asthma
benn
cowork
populationbas
cohort
studi
denmark
show
composit
matern
vagin
microfl
ora
aff
ect
wheez
spring
fi
rst
year
life
aff
ect
risk
asthma
children
age
year
wherea
ureaplasma
urealyticum
associ
infant
wheez
adjust
odd
ratio
staphylococcu
aureu
adjust
matern
antibiot
use
pregnanc
adjust
associ
asthma
child
year
age
defi
ned
use
asthmaspecifi
c
medic
howev
data
u
urealyticum
unaff
ect
adjust
antibiot
treatment
moreov
u
urealyticum
shown
invad
amniot
sac
reproduc
keskinisula
cowork
report
intrauterin
growth
potenti
pathogen
bacteria
bacteroid
spp
clostridium
spp
streptococcu
spp
associ
doctordiagnos
asthma
age
year
distort
microbiom
could
occur
administr
antibiot
matern
antibiot
use
could
therefor
aff
ect
child
risk
asthma
chang
vagin
gut
microbiom
mother
moreov
antibiot
cross
placenta
might
therefor
aff
ect
fetal
postnat
microbiota
child
crosssect
casecontrol
studi
children
asthma
control
age
year
calvani
cowork
identifi
ed
episod
matern
fever
proxi
measur
infect
associ
childhood
asthma
independ
matern
asthma
adjust
matern
antibiot
use
result
signifi
cant
suggest
primari
role
antibiot
studi
support
fi
nding
role
administr
antibiot
child
compar
mother
prone
bia
epidemiolog
studi
mani
children
given
antibiot
respiratori
troubl
confound
indic
sever
limit
valid
studi
fact
consid
children
receiv
antibiot
nonrespiratori
indic
posit
associ
disappear
environ
rich
microbi
tradit
european
farm
exposur
associ
protect
atop
sensitis
hay
fever
childhood
wheez
asthma
abund
divers
microbi
burden
within
environ
import
protect
role
childhood
asthma
timepoint
exposur
crucial
howev
bacteri
exposur
urban
environ
also
shown
invers
relat
atopi
asthma
whether
environment
exposur
aff
ect
human
airway
gut
microbiom
still
unknown
mice
biogeographi
habitat
shown
shape
divers
intestin
microbiota
addit
environment
microbi
exposur
might
directli
aff
ect
immun
respons
cord
blood
infant
born
mother
expos
farm
activ
farm
dairi
product
pregnanc
concentr
higher
compar
infant
born
mother
farm
contact
suggest
strengthen
antivir
respons
earli
life
moreov
innat
immun
receptor
persist
upregul
children
grew
farm
adapt
immun
also
aff
ect
cell
abund
capabl
suppress
tcell
prolifer
cord
blood
newborn
babi
farm
mother
babi
nonfarm
mother
furthermor
allergeninduc
product
cytokin
interleukin
interleukin
immunoglobulin
isotyp
ige
inhibit
igclass
switch
seem
reduc
farm
environ
bacteri
infect
regard
distort
equilibrium
microbi
commun
give
rise
overgrowth
one
speci
associ
matern
infect
urinari
tract
infect
chorioamnion
pregnanc
subsequ
wheez
asthma
children
assess
data
questionnair
medic
record
regist
kumar
cowork
investig
chorioamnion
assess
object
histolog
chang
result
studi
suggest
potenti
role
prenat
bacteri
infect
initi
wheez
asthma
children
postnat
childhood
infect
atyp
bacteria
chlamydia
mycoplasma
also
relat
increas
risk
develop
asthma
howev
similar
viru
infect
sever
host
factor
includ
famili
histori
allergi
preexist
atopi
impair
clearanc
bacteria
acut
infect
also
play
part
bacteri
infect
furthermor
children
earli
asthma
atopi
might
reduc
serum
concentr
bacteriaspecifi
c
igg
support
chang
underli
host
immun
respons
potenti
target
prevent
treatment
childhood
asthma
relat
either
virus
bacteria
host
factor
convey
risk
asthma
develop
import
rout
viral
transmiss
seem
viru
particl
via
selfinocul
conjunctiva
access
respiratori
mucosa
touch
contamin
surfac
henc
purpos
hand
hygien
import
although
fi
rst
result
antirsv
antibodi
palivizumab
prevent
viral
induc
wheez
promis
prematur
children
prevent
potenti
children
risk
asthma
investig
howev
prohibit
cost
discourag
clinic
applic
without
robust
scientifi
c
evid
antibiot
treatment
particularli
earli
life
might
harm
good
prevent
measur
nevertheless
antibiot
indispens
pneumonia
overt
bacteri
infect
macrolid
antibiot
might
role
prevent
asthma
exacerb
adult
sever
asthma
data
children
scarc
whether
manipul
microbiota
could
turn
succeed
still
open
debat
confl
ict
result
safeti
issu
infant
immuno
compromis
individu
present
evid
support
prebiot
contain
nutrient
oligosaccharid
foster
growth
benefi
cial
bacteria
colon
probiot
benefi
cial
bacteria
synbiot
contain
nutrient
benefi
cial
bacteria
manipul
gastrointestin
microbiom
eff
ectiv
prevent
asthma
although
evid
benefi
microbi
product
weak
futur
develop
applic
prevent
treatment
asthma
progress
view
strong
epidemiolog
evid
protect
microbi
exposur
approach
could
promis
long
safeti
administ
product
guarante
altern
host
factor
increas
suscept
viral
bacteri
infect
could
target
extern
interferon
applic
aim
reduc
viru
shed
especi
lower
airway
primari
infect
eff
ectiv
adult
asthma
prophylact
intranas
treatment
eff
ectiv
reduc
hrv
infect
adult
howev
advers
system
reaction
ethic
constraint
test
children
review
relat
cost
prohibit
broad
use
interferon
paediatr
popul
secondari
prevent
atopi
subcutan
sublingu
immunotherapi
possibl
immuno
therapi
start
earli
life
could
potenti
prevent
action
howev
subcutan
inject
accept
children
younger
year
sublingu
administr
test
young
children
administr
antiigeantibodi
omalizumab
decreas
rate
probabl
virusinduc
asthma
exacerb
innerc
school
children
result
yet
replic
view
outlin
evid
propos
comprehens
theori
role
virus
bacteria
develop
childhood
asthma
four
primari
compon
host
factor
could
attribut
develop
asthma
alter
airway
function
mechan
ii
impair
mucos
immun
respons
iii
impair
system
immun
respons
iv
atop
sensitis
fi
gure
compon
could
form
prenat
depend
genet
back
ground
mother
spring
matern
environ
mental
exposur
pregnanc
tobacco
smoke
antibiot
use
infect
microbi
environ
ment
virus
bacteria
mostli
interact
second
compon
patient
asthma
interfac
airway
environ
like
defect
disord
chang
epitheli
defenc
might
attribut
one
combin
factor
impair
repair
mechan
damag
epithelia
dysfunct
epitheli
barrier
defi
cient
innat
immun
respons
mucos
surfac
could
result
airway
infl
ammat
particularli
suitabl
condit
dysbiosi
overgrowth
bacteriathes
bacteria
might
turn
reinforc
airway
infl
ammat
likewis
disord
airway
mucosa
weaken
antivir
defenc
might
hamper
viru
clearanc
increas
damag
epitheli
surfac
viral
infect
viral
bacteri
commun
might
activ
interact
overgrowth
specifi
c
bacteria
follow
viral
infect
lower
respiratori
tract
suggest
bidirect
synerg
ie
viral
pre
disposit
bacteri
colonis
bacteri
pre
disposit
viral
colonis
although
viral
infect
might
also
aff
ect
immun
respons
pathogen
bacteria
whether
colonis
specifi
c
bacteria
identifi
ed
airway
patient
asthma
aff
ect
antivir
respons
unknown
third
compon
impair
system
immun
responsessuch
bia
infanc
delay
immun
maturationcould
involv
viral
bacteri
infect
colonis
might
interact
local
immun
respons
airway
mucosa
develop
atop
sensitis
could
turn
aff
ect
impair
system
immun
respons
innat
immun
mucos
surfac
thu
wide
diversifi
ed
network
interact
four
primari
compon
could
alreadi
establish
birth
fourth
compon
atopi
sensitis
could
import
allergen
exposur
might
induc
constant
lowlevel
infl
ammatori
state
airway
facilit
subsequ
allergen
uptak
airway
mucos
dendrit
cell
mediat
respons
viral
infect
trigger
local
system
chang
steadi
state
constant
basal
infl
ammat
local
directli
induc
via
bind
hrv
hous
dust
mite
allergen
tolllik
receptor
potenti
enhanc
eff
ect
postnat
two
major
develop
delin
timecours
fi
gure
transient
wheez
prompt
viral
infect
trigger
allergen
propos
individu
transient
wheez
normal
mucos
system
immun
respons
viral
bacteri
exposur
turn
chang
airway
function
mechan
might
play
essenti
part
manifest
symptom
earli
life
disappear
around
age
year
persist
wheez
later
develop
asthma
symptom
could
occur
might
determin
one
combin
four
primari
compon
birth
postnat
environment
exposur
nonatop
wheez
could
mainli
involv
impair
delay
mucos
system
immun
respons
might
matur
school
age
remiss
symptom
occur
individu
atop
sensitis
earli
life
viral
bacteri
infect
might
enhanc
airway
infl
ammat
therebi
chang
airway
function
eventu
result
chronic
asthma
environ
rich
microbi
exposur
turn
protect
chronic
cours
counterbal
impair
mucos
system
immun
respons
strengthen
antivir
innat
immun
respons
exposur
might
also
prevent
harm
bacteri
colonis
airway
mucosa
although
evid
mutual
virus
host
exist
natur
whether
also
role
good
virus
human
be
particularli
context
airway
diseas
unknown
search
pubm
mesh
term
wheez
asthma
combin
prenat
childhood
infect
larg
select
public
nov
mar
exclud
commonli
referenc
older
public
total
abstract
screen
also
search
refer
list
identifi
ed
articl
select
articl
judg
relev
review
articl
cite
provid
reader
detail
refer
although
concept
oversimplifi
ed
contain
mani
facet
compon
pathway
propos
conceptu
framework
could
help
relat
variou
eff
ect
viral
bacteri
infect
develop
asthma
evm
literatur
search
design
fi
gure
contribut
review
approv
fi
nal
version
declar
confl
ict
interest
